Literature DB >> 32007401

Established rheumatoid arthritis - Redefining the concept.

Katerina Chatzidionysiou1, George E Fragoulis2.   

Abstract

During the last few years, there has been a shift of focus in rheumatoid arthritis (RA) research towards earlier disease states. The terms early and established RA are inseparable, and having a clear definition of these two terms is crucial in conducting research and trying to understand the immunopathological mechanisms behind these different disease states. Established RA has been connected to chronic inflammation and a high burden of long-standing disease, with joint damage and comorbidities as a consequence of chronic inflammation. A chronological definition does not ensure us clear differentiation between early and established disease, because diagnosis can be delayed significantly. Similarly, a radiological definition does not ensure a clear differentiation either, as there is significant heterogeneity in the RA patient population, with some patients never developing structural damage, even after many years of disease. As the focus is now more on the early stages of disease, we propose to use the term established RA from the time of a definite clinical diagnosis of RA, irrespective of the symptoms' duration or the presence of irreversible damage, to distinguish established disease to a stage of undifferentiated arthritis (UA) or risk for developing RA, which might never progress to RA.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Early rheumatoid arthritis; Established RA; Rheumatoid arthritis; Window of opportunity

Year:  2020        PMID: 32007401     DOI: 10.1016/j.berh.2019.101476

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  3 in total

1.  Content, Structure and Delivery Characteristics of Yoga Interventions for Managing Rheumatoid Arthritis: A Systematic Review Protocol.

Authors:  Isha Biswas; Sarah Lewis; Kaushik Chattopadhyay
Journal:  Int J Environ Res Public Health       Date:  2022-05-17       Impact factor: 4.614

Review 2.  Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis.

Authors:  Ravi Raj Pal; Vasundhara Rajpal; Priya Singh; Shubhini A Saraf
Journal:  Pharmaceutics       Date:  2021-05-22       Impact factor: 6.321

3.  Prospective Studies on the Risk of Rheumatoid Arthritis: The European Risk RA Registry.

Authors:  Paul Studenic; Aase Hensvold; Arnd Kleyer; Annette van der Helm-van Mil; Arthur G Pratt; Daniela Sieghart; Gerhard Krönke; Ruth Williams; Savia de Souza; Susanne Karlfeldt; Martina Johannesson; Niels Steen Krogh; Lars Klareskog; Anca I Catrina
Journal:  Front Med (Lausanne)       Date:  2022-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.